What are the risks of investing in ALNY?
A
What are the risks of investing in ALNY?
🦉
Alnylam Pharmaceuticals, Inc. (ALNY)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOYvonne L. Greenstreet
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic...
Key Executives
| Name | Title |
|---|---|
| Bryan Andrew Supran | Chief Legal Officer |
| Christine Regan Akinc | Chief Corporate Communications Officer |
| Jeffrey V. Poulton | Chief Financial Officer & Executive Vice President |
| Kevin Joseph Fitzgerald | Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development |
| Melissa McLaughlin | Chief Human Resources Officer |
| Muthiah Manoharan | Senior Vice President of Innovation Chemistry & Distinguished Scientist and Member of Scientific Advisory Board |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A